Complement-dependent cytotoxicity (CDC) and Complement Receptor 3 (CR3; CD11b/CD18)-dependent cellular cytotoxicity (CR3-DCC) are important mechanisms through which tumor cells can be eliminated. This evidence concerns the gene ITGAM and neoplasm.